Letrozol 2.5

ACTIVE HALF-LIFE 2 days
CLASSIFICATION Non-steroidal aromatase inhibitor
DOSAGE 2.5 mg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Nakon Medical
LAB TEST See Document
WAREHOUSE International Warehouse 3
SUBSTANCE Letrozole ,

Discover Letrozole 2.5, a powerful anti-estrogen medication developed by Nakon Medical, renowned for its effectiveness in both medical and athletic arenas. In the medical field, it is primarily utilized to combat estrogen-driven cancers such as breast cancer in women. Athletes and bodybuilders turn to Letrozole to alleviate unwanted side effects from estrogenic steroids, such as water retention and gynecomastia in men.

This cutting-edge medication operates as a non-steroidal aromatase inhibitor, featuring Letrozole as its active ingredient. It is approved for human use, showcasing a non-steroidal composition that is free from androgenic effects, hepatotoxicity, and narcotic properties, making it a safe choice for users.

Upon administration, Letrozole 2.5 functions as an aromatase inhibitor, significantly lowering estrogen levels by an impressive 75-95% from baseline by targeting the cytochrome P450 component of the aromatase enzyme. As a third-generation aromatase inhibitor, it differs from its analog, Anastrozole, in mechanism. Unlike Clomid and Nolvadex, which block estrogen receptors, Letrozole directly reduces estrogen production.

Generally regarded as a safe medication with minimal side effects when used within recommended parameters, Letrozole can, however, lead to digestive disturbances (like nausea and dry mouth), central nervous system effects (including dizziness and mood changes), respiratory symptoms (such as cough and breathlessness), and musculoskeletal issues (from joint pain to potential osteoporosis) if misused. In the event of overdose, symptomatic treatment is advised.

Letrozole is designed for oral consumption, with optimal absorption achieved regardless of food intake, boasting a remarkable 99% bioavailability. The typical dosage is between 2.5 to 5 mg per day, tailored to individual requirements and tolerance levels.

Two prevalent usage strategies include: 1. Acting as a preventive tool against complications arising from estrogenic steroids. 2. Serving as supportive treatment during steroid cycles to manage estrogen-related side effects.

In both scenarios, Letrozole effectively mitigates estrogen-related issues, such as water retention, increased body fat, and gynecomastia in men.

Before starting Letrozole 2.5, it's crucial to consult a healthcare professional to identify any potential risks or contraindications. Women should be cautious of contraindications such as pregnancy, breastfeeding, and certain reproductive health concerns. Additionally, both genders should avoid the medication if they have allergies or hypersensitivity to its components, and it is not recommended for children.

Caution is advised for individuals with glucose-galactose malabsorption, lactase deficiency, and intolerance to lactase, as these conditions could lead to adverse effects. Typically, dosage adjustments are not necessary.

Keep out of reach of children. For adult use only.